Abstract
Glecaprevir/pibrentasvir in combination with sofosbuvir may serve as a safe and effective option for treatment of recurrent hepatitis C virus post-liv......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
